Cargando…
A Class I HDAC Inhibitor BG45 Alleviates Cognitive Impairment through the CaMKII/ITPKA/Ca(2+) Signaling Pathway
Alzheimer’s disease (AD) seriously endangers the health and life of elderly individuals worldwide. However, despite all scientific efforts, at the moment there are no effective clinical treatment options for AD. In this work, the effect of the class I histone deacetylase inhibitor (HDACI) BG45 on sy...
Autores principales: | Liu, Jingyun, Zhang, Chenghong, Wang, Jiale, Huang, Yufei, Shen, Di, Hu, Yingqiu, Chu, Haiying, Yu, Xuebin, Zhang, Liyuan, Ma, Haiying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9786203/ https://www.ncbi.nlm.nih.gov/pubmed/36558932 http://dx.doi.org/10.3390/ph15121481 |
Ejemplares similares
-
CaMKII points the way
por: Leslie, Mitch
Publicado: (2012) -
CaMKII in Cardiometabolic Disease
por: Ozcan, Lale, et al.
Publicado: (2014) -
Synaptic memory and CaMKII
por: Nicoll, Roger A., et al.
Publicado: (2023) -
Enhanced Cardiac CaMKII Oxidation and CaMKII-Dependent SR Ca Leak in Patients with Sleep-Disordered Breathing
por: Arzt, Michael, et al.
Publicado: (2022) -
Structure of the CaMKIIδ/Calmodulin Complex Reveals the Molecular Mechanism of CaMKII Kinase Activation
por: Rellos, Peter, et al.
Publicado: (2010)